Shorts

0:39
Making the most of networking at the LUGPA Annual Meeting
2 days ago
by
Benjamin H. Lowentritt, MD, FACS

0:20
New guidelines recognize penoscrotal decompression for priapism
3 days ago
by
Juan J. Andino, MD, MBA

0:35
Administrators, coordinators, and lab directors at LUGPA
6 days ago
by
Benjamin H. Lowentritt, MD, FACS

0:30
Expert: Belzutifan plus lenvatinib advances outcomes in advanced ccRCC
7 days ago
by
Daniel Heng, MD, MPH, FRCPC

0:57
What urine cell-free RNA can reveal about bladder cancer
8 days ago
by
Maximilian Diehn, MD, PhD

0:26
When voiding difficulty points to underactive bladder
9 days ago
by
Ariana L. Smith, MD

0:26
Dr. Lowentritt's LUGPA 2027 pick: Friday afternoon breakouts
10 days ago
by
Benjamin H. Lowentritt, MD, FACS

0:30
Correcting misconceptions about hormone therapy for GSM
14 days ago
by
Engy Habashy, MD

1:29
How gravity instillation may improve gem/doce feasibility
15 days ago
by
Adam B. Weiner, MD(+1 more)

0:50
Expert: Anktiva approval sets precedent for papillary-only NMIBC
16 days ago
by
JJ Zhang, MD
Advertisement
Advertisement
Trending on Urology Times
1
UGN-501 enters phase 1 testing for recurrent non–muscle invasive bladder cancer
2
Infertility care: Examining geographic gaps in access
3
Alicia Morgans, MD, discusses cognitive outcomes with darolutamide vs enzalutamide
4
ESMO 2026 On Location - Why pCR is not the whole story in cisplatin-ineligible MIBC
5






























